Our previous study showed that Semen sojae germinatum (SSG), a soy-derived Chinese medicinal material, have potential benefits for knee osteoarthritis (OA). This study was undertaken to identify the major effective sub-fraction of SSG. The 95% ethanol extract of SSG was successively fractionated into petroleum ether, ethyl acetate, n-butanol and aqueous fractions. Then we examined the effect of fractions on the inflammatory response and cell proliferation of primary human osteoarthritic chondrocytes stimulated by interleukin (IL)-1β, a recognized and common inducer of OA in vitro. Results showed that the petroleum ether, ethyl acetate and n-butanol extracts of SSG promoted cell-proliferation measured by MTT [3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazoliumbromide] assay, increased the transcript levels and nuclear translocation of cyclin D1, and inhibited the production of pro inflammatory mediator prostaglandin (PG)E 2 and nitric oxide (NO) induced by IL-1β in human OA chondrocytes, suggesting SSG extracts possessed chondro protective and anti-inflammatory properties. The ethyl acetate fraction was superior to other fractions. These data indicated SSG extracts might become a potential treatment option for humans with OA.
INTRODUCTION

Semen sojae germinatum (SSG) is a traditional
Chinese medicine, which is essentially dry and processed bean sprout coming from germinating mature seed of Chinese black soybean (Glycine max L. Merr.) variety. This soy derived medicinal material was recorded by "Shen Nong's Herbal Classic"(earliest pharmacopeia in ancient China which was written as early as 2000 years ago), later "Compendium of Materia Medica" written by Li Shizhen in the Ming Dynasty (CE 1368-1644), and has also been included in the current edition of Pharmacopoeia of People's Republic of China. In "Compendium of Materia Medica", SSG have been recorded as a valuable Chinese single herb for removing "Bi syndrome of bone" and dispelling "wind-hot-dampness", which are important indices for "knee pain" in traditional Chinese medicine. Knee pain is a common disease affecting about a quarter of people aged over 55 years old, and normal daily activities in about half of patients would be restricted when the pain is severe enough. 1 After excluding specific conditions such as inflammatory arthritis, an over whelming majority of knee pain is given the label of 'osteoarthritis' (OA). Knee OA is one of the most common degenerative diseases characterized by synovial inflammation and progressive loss of joint cartilage, which affects millions of aging people worldwide. However, the understanding of OA as a "wear and tear" disease has been recently shift to an inflammatory disease. 2, 3 Signs and symptoms of localized inflammation such as stiffness and joint effusion are presented as common clinical manifestations of knee OA. On the other hand, the evidence of cell death in osteoarthritic chondrocytes indicates that chondrocyte death/survival also plays a key role in OA pathogenesis. 4, 5 The proliferation and synthetic activity of cartilage and bone cells are generally considered to be involved in the regulation of physiological remodeling and cartilage healing, 6 mediate repair and protective processes in osteoarthritic cartilage and subchondral cancellous bone, thereby are advantageous to the treatment of OA. 7 Chondrocytes are the resident cells of articular cartilage, and responsible for the maintenance of extra cellular matrix. A definite negative co-relation has been clinically reported between the number of chondrocytes and the degree of cartilage damage. 8 Maintaining and promoting chondrocyte proli feration and viability could potentially delay the progression of cartilage degeneration during OA. The current treatments for OA (e.g. non steroidal antiinflammatory drugs, cortico steroids or intra-articular hyaluronic acid) are marginal effective even ineffective, or associated with serious adverse events. Under this circumstance, complementary and alternative medicine represented by Chinese herbal medicine has become a popular treatment option for knee OA patients around the world. 9, 10 In our previous study, 11 to investigate the preliminary effect of SSG on experimental OA, we have demonstrated that prepared SSG as feed could improve cartilage degeneration and cartilage matrix degradation, decrease the levels of inflammatory mediators in synovial fluid of osteoarthritic rabbit knee joints, suggesting SSG showed potential benefits for knee OA. Nevertheless, the active components of SSG and their pharmacological activities are still unclear. In the present study, we examined the effect of fractions extracted from SSG on the inflammatory response and cell proliferation of primary human osteoarthritic chondrocytes stimulated by inter leukin(IL)-1β, a recognized and common inducer of OA in vitro.
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MATERIALS AND METHODS
Preparation of the extracts from SSG
As described in our previous study, 11 SSG was prepared from sprouted Chinese black soybeans (Glycine max L. Merr.) referring to Pharmacopoeia of People's Republic of China (Edition 2010). Dried prepared SSG (1500 g) were crashed then extracted by reflux extraction with 95% ethanol at 50°C for 2-3 h. And this extraction step was repeated three times. The extracted liquid was pooled, filtered then concentrated at 50°C using a rotary evaporator. The decoction was vacuum dried to obtain the concentrated residue, which was the crude extract from SSG (46.5g). Then, the crude extract were suspended in distilled water and partitioned sequentially with petroleum ether, ethyl acetate, and n-butanol to obtain respective fractions. Each organic fraction was then evaporated to dryness separately, and yielded a petroleum ether extract (PEE) (4.0 g), an ethyl acetate extract (EAE) (3.2 g), and an n-butanol extract (NBE) (6.1 g), while the remaining was aqueous fractions (AF) of SSG (14.0 g). Each extract were respectively dissolved in dimethyl sulfoxide at a concentration of 10,000 μg/ml as stock solution.
Chondrocyte culture and treatment
Human osteoarthritic chondrocytes were isolated from pooled cartilage samples obtained from the femoral chondyle and tibia plateau of 4 female OA patients undergoing total knee arthroplasty. The average age of patients was 68.7 years (range of 65-71). OA was diagnosed according to the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. 13 This study was approved by the Ethics Committee of Hubei Woman and Child Hospital, and informed consent was obtained from each patient. Cartilage was incubated with 1 mg/ml trypsin (Sigma, MI, USA) for 1 hour followed by an overnight digestion in 0.5 mg/ml collagenase type II (Worthington, Lakewood, NJ) in a 37°C water bath. The resulting cell suspension was filtered twice using 70 μm nylon meshes, washed, and then centrifuged for 10 min at 700×g. Trypan blue viability test showed 90%-95% of the recovered cells were alive. Primary cells cultures were seeded at 1-2×10 5 cells/ml in a 25 cm 2 flask at 37°C, 5% CO 2 in DMEM/ F12 medium supplemented with 10% fetal calf serum (FCS), 100 U/mL penicillin and 100 U/ml streptomycin. All chondrocytes were used for the experiments at the second passage. OA chondrocytes were then seeded into six-well plates at 6×10 5 cells/well and incubated for 24 hours. Culture medium was then replaced with serum starved media (0.5% FCS) and exposed to 5 ng/ml IL -1β (Sigma, MI, USA) for 24 h. Untreated cells were used as controls.
Chondrocyte proliferation and viability assay
The effect of various amounts of different SSG extracts (1 000, 500, 250, 125, 62.5, 31.3, 15.6, 7.8, and 3.9 µg/mL) on the chondrocyte proliferation and viability was studied using MTT (3-(4,5-dimethylthiazolyl-2)-2,5-diphe-nyltetrazoliumbromide) assay in accordance with the manufacturer's instructions (R & D Systems). The resulting absorbance was measured at 570 nm.
Enzyme-Linked Immunosorbent Assay (ELISA) for prostaglandin (PG)E 2 in culture supernatant produced by chondrocytes
The levels of PGE 2 released from cultured chondrocytes were detected by specific ELISA kit (R&D Systems, Inc., Minneapolis, MN, USA) according to the instructions of the manufacturer.
Measurement of nitric oxide (NO) in culture supernatant produced by chondrocytes
The concentration of NO in culture supernatant produced by chondrocytes was measured by Griess reagent according to the instructions of the manufacturer (Jiancheng, Nanjing, China). Detection of NO concentration was performed by estimating the level of nitrite, a NO metabolite.
Quantitative real-time polymerse chain reaction (PCR)
Total RNA of monolayer cultured osteoarthritic chondrocytes was isolated using TRIzol Reagent (In vitro gen, USA). After quantifying the isolated RNA using a spectrophotometer, 2-lg aliquots were reverse transcribed using a Transcript or First Strand c DNA Synthesis Kit (Genecopoiea, USA.). The primer sequences of Cyclin D1 are 5'-TCTACACCGACAACTCCATCCG-3' (forward) and 5'-TCTGG CATTTTGGAGAGGAAGTG-3' (reverse). Real-time PCR was carried out in an Applied Biosystems Step One Plus™ Real-Time PCR System. Levels of cyclin D1 mRNA were normalized to those of β-actin.
Immuno fluorescence
Cells were stained with the anti-cyclin D1 primary antibodies, followed by peroxidase-conjugated secondary antibodies (Southern Biotech, Birmingham, Al). Immunostains were visualized using a fluorescent tyramide reagent (TSA-direct NEL-701, PerkinElmer, Waltham, MA).
Statistical analysis
The statistical software package SPSS 12.0 was used. The data are presented as the means ± S.D. of five independent experiments. The statistical significance of differences was deter mined by one-way analysis of variance. p<0.05 was considered to indicate statistical significance.
RESULTS
Effect of SSG extracts on chondrocyte proliferation and viability
To explore the effect of SSG extracts on chondrocyte growth and determine their appropriate concentration ranges, MTT assay was performed on chondrocytes for the detection of cell proliferation and viability following exposure to different extracts. As shown in Figure 1 , PEE at the concentrations of 62.5, 125 and 250 µg/mL showed 23.7%, 28.9% and 31.6% increase of chondrocyte proliferation and viability, respectively (p<0.05). The concentration of EAE at 62.5-250 μg/m and NBE at 250 μg/mL respectively showed significant protection for chondrocytes against IL-1β-induced damage (p<0.05; p<0.01). These results indicated that PEE, EAE and NBE might be responsible for the growth promoting effect of SSG on OA chondrocytes. Despite the fact that no significant effect of AF was found, the concentration range from 62.5 to 250 µg/mL was appropriate for most of the extracts, especially, a concentration of 125 µg/ml was acceptable in most cases. To confirm the effect of SSG extracts on chondrocyte proliferation, the mRNA expression level of cyclin D1, a major cell cycle regulatory switch in proliferating cells, in OA chondrocytes treated with SSG extracts at concentration of 62.5-250 µg/mL was measured with Real-time PCR, and subcellular locations of cyclin D1 in chondrocytes treated with 125 µg/mL different extracts were determined by immunofluorescence staining. As shown in Figure 2A , PEE and NBE at concentration of 250 µg/mL increased the mRNA expression level of cyclin D1 in IL-1β-induced human osteoarthritic chondrocytes (p<0.05). Among the different solvent fractions, EAE was remarkably effective one in upregulating cyclin D1 expression of OA chondrocytes, which was manifested as 50.0-92.7% increase at concentrations of 62.5-250 µg/mL (p<0.05; p<0.01). Cyclin D1 immuno reactivity was found mainly in the cytoplasm in control and IL-1β-induced chondrocytes. And further increased nuclear cyclin D1 were detected in cells treated with 125 µg/mL EAE ( Figure 2B ). 2 and NO production in human osteoarthritic chondrocytes PGE 2 , as an important pro inflammatory mediator, has long been demonstrated to be one of the major catabolic mediators involved in cartilage degradation that push forward the progression of OA disease. 14 The PGE 2 level in the supernatant was assessed using an ELISA assay. As shown in Figure 3 , upon IL-1 β stimulation and NO levels in the supernatant were assessed using ELISA assay and Griess method, respectively. *p<0.05,** p<0.01, compared with IL-1β-stimulated human osteoarthritic chondrocytes. n = 5 in each group. PEE: petroleum ether extract; EAE: ethyl acetate extract; NBE: n-butanol extract; AF:aqueous fractions.
Effect of SSG extracts on IL-1β-induced PGE
(5 ng/ml), chondrocytes produced over 5 times more PGE 2 than unstimulated chondrocytes (p<0.01). Importantly, treatment of chondrocytes with PEE, EAE and NBE further reduced the PGE 2 release induced by IL-1β stimulation (p<0.05;p<0.01). Over production of NO have also been recognized as an inflammatory mediator involved in the pathophysiology of OA. Increased NO levels in plasma have been reported in patients with OA. 15, 16 More over, serum NO content was found correlated with pain scores in response to pressure, total Lequesne's scores, and swelling scores of OA, thus has been believed as a biochemical factor implicated in joint degeneration. 16 We found PEE and EAE of SSG were effective in attenuating IL-1β-induced NO overproduction in chondrocytes (p<0.05; p<0.01, Figure 3 ). In general, these results demonstrated that PEE, EAE and NBE from SGG might serve to control and resolve inflammation and cartilage degradation during OA, and EAE was more active than the other extracts.
DISCUSSION
Accumulating evidences have suggested that soy derived products were safe and beneficial in the management of OA. [17] [18] [19] The efficacy of soy protein supplementation in relieving the pain and discomfort associated with OA has been reported in a parallel, randomized, doubleblind, placebo-controlled study. 17 Specific components of soy, such as genistein, daidzein and glycitein, have been shown exert protective effects via reducing inflammation or modulating cartilage metabolism in various OA models in vitro or in vivo. 18 Although there was scant evidence about the effect of soy isoflavone in the setting of OA, the anti-inflammatory properties of isoflavones have been well-described, 20 and also provide the rationale for the protective effect of soy derived products in conditions such as OA. 17 In addition, soybean unsaponifiables as other components of soy have been shown to modulate OA pathogenesis by inhibiting catabolic pathways, fibrinolysis and inflammatory cytokines, promoting cartilage repair, and could reduce stiffness and pain while improving joint function at the clinical level. 19 Since SSG essentially is a kind of processed bean sprout, these above researches further support the potential to use SSG and its extracts as protective agents against OA. As a rheumatism-dispelling agent, SSG has been used for the control of knee joint pain and arthritis in Chinese medicine for over 2000 years. Based on our previous study on the protective effect of SSG against the development of knee OA, 11 this study has conducted a pharmacological activity screen on the extracts got from SSG looking at the chondro protective and anti-inflammatory activities in an in vitro model of OA. We further confirmed that, overall, the petroleum ether, ethyl acetate and n-butanol extracts of SSG promoted cell-proliferation measured by MTT assay, increased the transcript levels and nuclear translocation of cyclin D1, and inhibited the production of pro inflammatory mediator PGE 2 and NO induced by IL-1β in human OA chondrocytes, suggesting extracts from SSG possessed chondro protective and anti-inflammatory properties. These data indicated that, being soy-derived safe products, the extracts of SSG might become a potential treatment option for humans with OA. There into, the ethyl acetate fraction was superior to other fractions in protecting chondrocytes and reducing IL-1β-induced inflammation. However, the aqueous fractions had almost no chondrocyte protection and anti-inflammatory effect. The different activities of diverse polar solvents extracts of SSG might be due to the differences in compositions. Therefore, further phyto chemical investigations to determine the active molecules in each of the tested extracts are needed to underline the outcome. And it could be deduced that the ethyl acetate fraction contains high amount of the constituents which are responsible for the protective effect against OA. Besides, only one time point (incubation of chondrocytes with extracts for 24 hours) was selected in this study to evaluate the chondro protective and antiinflammatory activities of different extracts from SSG at different doses. Based on the preliminary results from the present study at one time point, further researches were also needed to assess the activity of active extracts such as PEE, EAE and NBE from SGG on a longer/ different time points, in order to reflect the definitive activity of the extracts. In addition, as a soy derived product and widely-used Chinese medicine, SSG ought to possess an excellent safety profile. Accordingly, in the present study, MTT assay also showed all the extracts of SSG cause no direct cytotoxicity on human chondrocytes.
CONCLUSION
Results from this study showed that the petroleum ether, ethyl acetate and n-butanol extracts of SSG promoted cell-proliferation, increased the transcript levels and nuclear translocation of cyclin D1, and inhibited the production of pro inflammatory mediator PGE 2 and NO induced by IL-1β in human OA chondrocytes, suggesting SSG extracts possessed chondro protective and anti-inflammatory properties. These data may provide valuable evidence for the traditional use of SSG in removing "Bi syndrome of bone" and dispelling "windhot-dampness", indicate SSG extracts might become a potential treatment option for humans with OA. The ethyl acetate fraction was superior to other fractions. It would be of great interest to further elucidate the structures of components responsible for the protective effect against OA.
